The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
Open accessAbstract
Graves' disease (GD) is a systemic autoimmune disorder characterized by the infiltration of thyroid antigen-specific T cells into thyroid-stimulating hormone receptor (TSH-R)-expressing tissues. Stimulatory autoantibodies (Ab) in GD activate the TSH-R leading to thyroid hyperplasia and unregulated thyroid hormone production and secretion. Diagnosis of GD is straightforward in a patient with biochemically confirmed thyrotoxicosis, positive TSH-R-Ab, a hypervascular and hypoechoic thyroid gland (ultrasound), and associated orbitopathy. In GD, measurement of TSH-R-Ab is recommended for an accurate diagnosis/differential diagnosis, prior to stopping antithyroid drug (ATD) treatment and during pregnancy. Graves' hyperthyroidism is treated by decreasing thyroid hormone synthesis with the use of ATD, or by reducing the amount of thyroid tissue with radioactive iodine (RAI) treatment or total thyroidectomy. Patients with newly diagnosed Graves' hyperthyroidism are usually medically treated for 12-18 months with methimazole (MMI) as the preferred drug. In children with GD, a 24- to 36-month course of MMI is recommended. Patients with persistently high TSH-R-Ab at 12-18 months can continue MMI treatment, repeating the TSH-R-Ab measurement after an additional 12 months, or opt for therapy with RAI or thyroidectomy. Women treated with MMI should be switched to propylthiouracil when planning pregnancy and during the first trimester of pregnancy. If a patient relapses after completing a course of ATD, definitive treatment is recommended; however, continued long-term low-dose MMI can be considered. Thyroidectomy should be performed by an experienced high-volume thyroid surgeon. RAI is contraindicated in Graves' patients with active/severe orbitopathy, and steroid prophylaxis is warranted in Graves' patients with mild/active orbitopathy receiving RAI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rapoport, B., & McLachlan, S. M. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1098 · Cited by 93
RetractedStagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., Sullivan, S., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0087 · Cited by 2,942
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938 · cited 5×
“If digox-in is used, increased doses are often needed in the thyro-toxic state [2, 5, 6, 72].”
BackgroundMethodInfluentialSmith, T. J., & Hegedüs, L. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510030 · Cited by 1,257
Self-citationThyroid Function and Human Reproductive Health
Krassas, G. E., Poppe, K., & Glinoer, D. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0041 · Cited by 1,223
Self-citationThe Importance of Surgeon Experience for Clinical and Economic Outcomes From Thyroidectomy
Sosa, J. A., Bowman, H. M., Tielsch, J. M., Powe, N. R., Gordon, T. A., & Udelsman, R. (1998) · Annals of Surgery · doi:10.1097/00000658-199809000-00005 · Cited by 1,118 · cited 1×
“To minimize the risk of complications (hypoparathy-roidism, laryngeal nerve palsy, wound infection, hemorrhage), surgery should be performed by a skilled high-volume surgeon [112].”
BackgroundBahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
Cooper, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra042972 · Cited by 1,008
Bartalena, L., Baldeschi, L., Boboridis, K., Eckstein, A., Kahaly, G. J., Marcocci, C., Perros, P., Salvi, M., & Wiersinga, W. M. (2016) · European Thyroid Journal · doi:10.1159/000443828 · Cited by 943
Self-citationLife-Threatening Thyrotoxicosis: Thyroid Storm
Burch, H. B., & Wartofsky, L. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30165-8 · Cited by 852
Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia
Edafe, O., Antakia, R., Laskar, N., Uttley, L., & Balasubramanian, S. P. (2014) · British Journal of Surgery · doi:10.1002/bjs.9384 · Cited by 732
Thyroid Hormone Action in the Heart
Kahaly, G. J., & Dillmann, W. H. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0033 · Cited by 717
Self-citationRelation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy
Bartalena, L., Marcocci, C., Bogazzi, F., Manetti, L., Tanda, M. L., Dell'Unto, E., Bruno-Bossio, G., Nardi, M., Bartolomei, M. P., Lepri, A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380201 · Cited by 715
Self-citationSelenium and the Course of Mild Graves' Orbitopathy
Marcocci, C., Kahaly, G. J., Krassas, G. E., Bartalena, L., Prummel, M., Stahl, M., Altea, M. A., Nardi, M., Pitz, S., Boboridis, K., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012985 · Cited by 619
Self-citationSubclinical hyperthyroidism and the risk of coronary heart disease and mortality
Collet, T.-H., Gussekloo, J., Bauer, D. C., den Elzen, W. P. J., Cappola, A. R., Balmer, P., Iervasi, G., Åsvold, B. O., Sgarbi, J. A., Völzke, H., et al. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.402 · Cited by 572
The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies*
Rapoport, B., Chazenbalk, G. D., Jaume, J. C., & McLachlan, S. M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0352 · Cited by 551
Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism
Tallstedt, L., Lundell, G., Tørring, O., Wallin, G., Ljunggren, J.-G., Blomgren, H., & Taube, A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262603 · Cited by 521
Gencer, B., Collet, T.-H., Virgini, V., Bauer, D. C., Gussekloo, J., Cappola, A. R., Nanchen, D., den Elzen, W. P. J., Balmer, P., Luben, R. N., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.096024 · Cited by 517
Diagnostic Criteria, Clinical Features, and Incidence of Thyroid Storm Based on Nationwide Surveys
Akamizu, T., Satoh, T., Isozaki, O., Suzuki, A., Wakino, S., Iburi, T., Tsuboi, K., Monden, T., Kouki, T., Otani, H., et al. (2012) · Thyroid® · doi:10.1089/thy.2011.0334 · Cited by 469
Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis
Coles, A. J., Wing, M., Smith, S., Coraddu, F., Greer, S., Taylor, C., Weetman, A., Hale, G., Chatterjee, V. K., Waldmann, H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02429-0 · Cited by 453
Laurberg, P., Wallin, G., Tallstedt, L., Abraham-Nordling, M., Lundell, G., & Tørring, O. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0450 · Cited by 428
Brix, T. H., Kyvik, K. O., Christensen, K., & Hegedüs, L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7242 · Cited by 406
Self-citationCancer Mortality Following Treatment for Adult Hyperthyroidism
Ron, E. (1998) · JAMA · doi:10.1001/jama.280.4.347 · Cited by 377
Applications of a New Chemiluminometric Thyrotropin Assay to Subnormal Measurement*
SPENCER, C. A., LoPRESTI, J. S., PATEL, A., GUTTLER, R. B., EIGEN, A., SHEN, D., GRAY, D., & NICOLOFF, J. T. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-2-453 · Cited by 371
LAURBERG, P., PEDERSEN, K. M., VESTERGAARD, H., & SIGURDSSON, G. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00368.x · Cited by 361
Immunogenetics of autoimmune thyroid diseases: a comprehensive review
Lee, H. J., Li, C. W., Hammerstad, S. S., Stefan, M., & Tomer, Y. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.07.009 · Cited by 351
A 2011 Survey of Clinical Practice Patterns in the Management of Graves' Disease
Burch, H. B., Burman, K. D., & Cooper, D. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2802 · Cited by 345
Subclinical Thyroid Dysfunction and Fracture Risk: A Meta-analysis
Blum, M. R., Bauer, D. C., Collet, T.-H., Fink, H. A., Cappola, A. R., da Costa, B. R., Wirth, C. D., Peeters, R. P., Åsvold, B. O., den Elzen, W. P. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.5161 · Cited by 343
Bonnema, S. J., & Hegedüs, L. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1030 · Cited by 339
Self-citationBartalena, L., & Tanda, M. L. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0806317 · Cited by 336
Self-citationBiondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323
Self-citationBartalena, L., Marcocci, C., Bogazzi, F., Panicucci, M., Lepri, A., & Pinchera, A. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911163212001 · Cited by 318
Self-citationTorring, O. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.2986 · Cited by 311
Swiglo, B. A., Murad, M. H., Schünemann, H. J., Kunz, R., Vigersky, R. A., Guyatt, G. H., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1907 · Cited by 302
Diagnosis and management of Graves disease: a global overview
Bartalena, L. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.193 · Cited by 296
Self-citationPerros, P., Crombie, A. L., Matthews, J. N. S., & Kendall‐Taylor, P. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00516.x · Cited by 288
Nakamura, H., Noh, J. Y., Itoh, K., Fukata, S., Miyauchi, A., Hamada, N., & Working Group of the Japan Thyroid Association for the Guideline of the Treatment of Graves’ Disease (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2135 · Cited by 277
Birth Defects After Early Pregnancy Use of Antithyroid Drugs: A Danish Nationwide Study
Andersen, S. L., Olsen, J., Wu, C. S., & Laurberg, P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2831 · Cited by 267
Träisk, F., Tallstedt, L., Abraham-Nordling, M., Andersson, T., Berg, G., Calissendorff, J., Hallengren, B., Hedner, P., Lantz, M., Nyström, E., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0747 · Cited by 262
High Dose 131I Therapy for the Treatment of Hyperthyroidism Caused by Graves' Disease
Alexander, E. K. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.3.1073 · Cited by 251
Satoh, T., Isozaki, O., Suzuki, A., Wakino, S., Iburi, T., Tsuboi, K., Kanamoto, N., Otani, H., Furukawa, Y., Teramukai, S., et al. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0336 · Cited by 251
Sundaresh, V., Brito, J. P., Wang, Z., Prokop, L. J., Stan, M. N., Murad, M. H., & Bahn, R. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1954 · Cited by 250
Antithyroid drug regimen for treating Graves’ hyperthyroidism
Abraham, P., Avenell, A., McGeoch, S. C., Clark, L. F., & Bevan, J. S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003420.pub4 · Cited by 249
Fetal and Neonatal Hyperthyroidism and Hypothyroidism due to Maternal TSH Receptor Antibodies
McKENZIE, J. M., & ZAKARIJA, M. (1992) · Thyroid · doi:10.1089/thy.1992.2.155 · Cited by 248
The Use of Antithyroid Drugs in Pregnancy and Lactation
Mandel, S. J., & Cooper, D. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.6.2354 · Cited by 239
Rubin, P. C. (1981) · New England Journal of Medicine · doi:10.1056/nejm198111263052205 · Cited by 239
Strieder, T. G. A., Prummel, M. F., Tijssen, J. G. P., Endert, E., & Wiersinga, W. M. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01862.x · Cited by 234
Cardiovascular involvement in patients with different causes of hyperthyroidism
Biondi, B., & Kahaly, G. J. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.105 · Cited by 230
Self-citationColor-flow Doppler sonography in Graves disease: "thyroid inferno"
Ralls, P., Mayekawa, D., Lee, K., Colletti, P., Radin, D., Boswell, W., & Halls, J. (1988) · American Journal of Roentgenology · doi:10.2214/ajr.150.4.781 · Cited by 225
Lytton, S. D., Ponto, K. A., Kanitz, M., Matheis, N., Kohn, L. D., & Kahaly, G. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2470 · Cited by 219
Self-citationAggravation of Thyrotoxicosis in Early Pregnancy and after Delivery in Graves' Disease*
AMINO, N., TANIZAWA, O., MORI, H., IWATANI, Y., YAMADA, T., KURACHI, K., KUMAHARA, Y., & MIYAI, K. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-1-108 · Cited by 211
Walter, M. A., Briel, M., Christ-Crain, M., Bonnema, S. J., Connell, J., Cooper, D. S., Bucher, H. C., Müller-Brand, J., & Müller, B. (2007) · BMJ · doi:10.1136/bmj.39114.670150.be · Cited by 202
Acharya, S. H., Avenell, A., Philip, S., Burr, J., Bevan, J. S., & Abraham, P. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03279.x · Cited by 200
A 2013 European survey of clinical practice patterns in the management of Graves' disease
Bartalena, L., Burch, H. B., Burman, K. D., & Kahaly, G. J. (2016) · Clinical Endocrinology · doi:10.1111/cen.12688 · Cited by 197
Self-citationTozzoli, R., Bagnasco, M., Giavarina, D., & Bizzaro, N. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.07.003 · Cited by 195
Long-Term Follow-up Study of Compensated Low-Dose131I Therapy for Graves' Disease
Sridama, V., McCormick, M., Kaplan, E. L., Fauchet, R., & DeGroot, L. J. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408163110702 · Cited by 190
Vos, X. G., Endert, E., Zwinderman, A. H., Tijssen, J. G. P., & Wiersinga, W. M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3644 · Cited by 188
Sawka, A. M., Lakra, D. C., Lea, J., Alshehri, B., Tsang, R. W., Brierley, J. D., Straus, S., Thabane, L., Gafni, A., Ezzat, S., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03222.x · Cited by 181
Analysis of 754 Cases of Antithyroid Drug-Induced Agranulocytosis Over 30 Years in Japan
Nakamura, H., Miyauchi, A., Miyawaki, N., & Imagawa, J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2569 · Cited by 180
Hegedüs, L. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70190-0 · Cited by 179
Self-citationLaurberg, P., Bournaud, C., Karmisholt, J., & Orgiazzi, J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0663 · Cited by 178
Dissimilar Hepatotoxicity Profiles of Propylthiouracil and Methimazole in Children
Rivkees, S. A., & Szarfman, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2546 · Cited by 177
Tallstedt, L., Lundell, G., Blomgren, H., & Bring, J. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300494 · Cited by 171
Watanabe, N., Narimatsu, H., Noh, J. Y., Yamaguchi, T., Kobayashi, K., Kami, M., Kunii, Y., Mukasa, K., Ito, K., & Ito, K. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2221 · Cited by 167
Thyroid Storm: A Japanese Perspective
Akamizu, T. (2017) · Thyroid · doi:10.1089/thy.2017.0243 · Cited by 160
Erbil, Y., Ozluk, Y., Giriş, M., Salmaslıoglu, A., Issever, H., Barbaros, U., Kapran, Y., Özarmağan, S., & Tezelman, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0229 · Cited by 157
Perros, P., Kendall-Taylor, P., Neoh, C., Frewin, S., & Dickinson, J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0507 · Cited by 156
Cooper, D. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030185 · Cited by 156
Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves’ orbitopathy
Smith, T. J., Hegedűs, L. D., & Douglas, R. S. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.10.002 · Cited by 152
Self-citationCigarette Smoking and Risk of Clinically Overt Thyroid Disease
Brix, T. H., Hansen, P. S., Kyvik, K. O., & Hegedűs, L. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.5.661 · Cited by 148
Self-citationLéger, J., Gelwane, G., Kaguelidou, F., Benmerad, M., Alberti, C., & the French Childhood Graves' Disease Study Group (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1944 · Cited by 144
Chen, F., Day, S. L., Metcalfe, R. A., Sethi, G., Kapembwa, M. S., Brook, M. G., Churchill, D., de Ruiter, A., Robinson, S., Lacey, C. J., et al. (2005) · Medicine · doi:10.1097/01.md.0000159082.45703.90 · Cited by 142
Nyström, H. F., Jansson, S. K. G., & Berg, G. E. B. (2013) · Clinical Endocrinology · doi:10.1111/cen.12060 · Cited by 141
Ending Propylthiouracil-Induced Liver Failure in Children
Rivkees, S. A., & Mattison, D. R. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0809750 · Cited by 140
Remission of Graves’ disease during anti-thyroid drug therapy. Time to reconsider the mechanism?
Laurberg, P. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02295 · Cited by 139
Clinical Relevance of Thyroid-Stimulating Immunoglobulins in Graves' Ophthalmopathy
Ponto, K. A., Kanitz, M., Olivo, P. D., Pitz, S., Pfeiffer, N., & Kahaly, G. J. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.03.030 · Cited by 139
Self-citationKung, A. W. C., Yau, C., & Cheng, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.2.7913934 · Cited by 139
Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine
Azizi, F., Ataie, L., Hedayati, M., Mehrabi, Y., & Sheikholeslami, F. H. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01904 · Cited by 139
Nedrebo, B., Holm, P., Uhlving, S., Sorheim, J., Skeie, S., Eide, G., Husebye, E., Lien, E., & Aanderud, S. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470583 · Cited by 132
Lai, A., Sassi, L., Compri, E., Marino, F., Sivelli, P., Piantanida, E., Tanda, M. L., & Bartalena, L. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2130 · Cited by 129
Self-citationVariation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel.
McLeod, D. S. A., Caturegli, P., Cooper, D. S., Matos, P. G., & Hutfless, S. (2014) · JAMA · doi:10.1001/jama.2013.285606 · Cited by 128
Can we predict relapse in Graves’ disease? Results from a systematic review and meta-analysis
Struja, T., Fehlberg, H., Kutz, A., Guebelin, L., Degen, C., Müeller, B., & Schüetz, P. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0725 · Cited by 126
Kahaly, G. J., Diana, T., Glang, J., Kanitz, M., Pitz, S., & König, J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1220 · Cited by 124
Self-citationBrito, J. P., Schilz, S. R., Ospina, N. S., Rodríguez‐Gutiérrez, R., Maraka, S., Sangaralingham, L. R., & Montori, V. M. (2016) · Thyroid · doi:10.1089/thy.2016.0222 · Cited by 122
Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK
Pearce, S. H. S. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02135.x · Cited by 119
Self-citationMarcocci, Bruno‐Bossio, Manetti, Tanda, M. L., Miccoli°, Iacconi, Bartolomei, Nardi, Pinchera, & Bartalena (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00843.x · Cited by 118
Diana, T., Brown, R. S., Bossowski, A. T., Segni, M., Niedziela, M., König, J., Bossowska, A., Ziora, K. T., Hale, A., Smith, J. R., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4026 · Cited by 118
Self-citationLillevang‐Johansen, M., Abrahamsen, B., Jørgensen, H. L., Brix, T. H., & Hegedűs, L. D. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00166 · Cited by 117
Self-citationLaurberg, P., & Andersen, S. L. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0135 · Cited by 115
Antithyroid drug‐related hepatotoxicity in hyperthyroidism patients: a population‐based cohort study
Wang, M., Lee, W., Huang, T., Chu, C., & Hsieh, C. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12336 · Cited by 114
Emiliano, A. B., Governale, L. A., Parks, M. A., & Cooper, D. S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2752 · Cited by 112
Villagelin, D., Romaldini, J. H., dos Santos, R. B., Milkos, A. B. B. P., & Ward, L. S. (2015) · Thyroid · doi:10.1089/thy.2015.0195 · Cited by 109
Antithyroid Drug Side Effects in the Population and in Pregnancy
Andersen, S. L., Olsen, J., & Laurberg, P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4274 · Cited by 107
Abeillon-du Payrat, J., Chikh, K., Bossard, N., Bretones, P., Gaucherand, P., Claris, O., Charrié, A., Raverot, V., Orgiazzi, J., Borson-Chazot, F., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0254 · Cited by 107
Chen, P., Shih, S., Wang, P., Lin, Y., Chu, C., Lin, J., Chen, S., Chang, C.-C., Huang, T., Tsai, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms8633 · Cited by 107
Ohye, H., Minagawa, A., Noh, J. Y., Mukasa, K., Kunii, Y., Watanabe, N., Matsumoto, M., Suzuki, M., Yoshihara, A., Ito, K., et al. (2014) · Thyroid® · doi:10.1089/thy.2012.0612 · Cited by 106
Genovese, B. M., Noureldine, S. I., Gleeson, E., Tufano, R. P., & Kandil, E. H. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2606-x · Cited by 101
Color Flow Doppler Sonography for the Etiologic Diagnosis of Hyperthyroidism
Erdoğan, M. F., Anıl, C., Cesur, M., Başkal, N., & Erdoğan, G. (2007) · Thyroid · doi:10.1089/thy.2006.0104 · Cited by 98
Momotani, N., Hisaoka, T., Noh, J. Y., Ishikawa, N., & Ito, K. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.3.1517362 · Cited by 98
Bioassays for TSH-receptor autoantibodies: An update
Lytton, S. D., & Kahaly, G. J. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.08.018 · Cited by 97
Self-citationHallberg, P., Eriksson, N., Ibáñez, L., Bondon‐Guitton, E., Kreutz, R. H., Carvajal, A., Lucena, M. I., Ponce, E. S., Molokhia, M., Martin, J. J., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00113-3 · Cited by 95
The Dilemma of How to Manage Graves' Hyperthyroidism in Patients with Associated Orbitopathy
Bartalena, L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2329 · Cited by 93
Self-citationGraves’ Orbitopathy Activation after Radioactive Iodine Therapy with and without Steroid Prophylaxis
Vannucchi, G., Campi, I., Covelli, D., Dazzi, D., Currò, N., Simonetta, S., Ratiglia, R., Beck-Peccoz, P., & Salvi, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0506 · Cited by 92
de los Santos, E. T. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390030032006 · Cited by 92
Korelitz, J. J., McNally, D. L., Masters, M. N., Li, S. X., Xu, Y., & Rivkees, S. A. (2013) · Thyroid® · doi:10.1089/thy.2012.0488 · Cited by 91
Bonnema, S. J., Bennedbæk, F. N., Veje, A., Marving, J., & Hegedűs, L. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0247 · Cited by 90
Self-citationLaurberg, P., Berman, D. C., Andersen, S., & Pedersen, I. B. (2011) · Thyroid · doi:10.1089/thy.2011.0039 · Cited by 87
Brandt, F., Thvilum, M., Almind, D., Christensen, K., Green, A., Hegedüs, L., & Brix, T. H. (2013) · Thyroid · doi:10.1089/thy.2012.0500 · Cited by 86
Self-citationSubclinical Thyroid Dysfunction and the Risk for Fractures: A Systematic Review and Meta-analysis
Wirth, C. D., Blum, M. R., da Costa, B. R., Baumgartner, C., Collet, T.-H., Medici, M., Peeters, R. P., Aujesky, D., Bauer, D. C., & Rodondi, N. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0125 · Cited by 85
Predictors of Malignancy in Patients with Cytologically Suspicious Thyroid Nodules
Castro, M. R., Espiritu, R. P., Bahn, R. S., Henry, M. R., Gharib, H., Caraballo, P. J., & Morris, J. C. (2011) · Thyroid · doi:10.1089/thy.2011.0146 · Cited by 85
Highly variable sensitivity of five binding and two bio-assays for TSH-receptor antibodies
Diana, T., Wüster, C. C., Kanitz, M., & Kahaly, G. J. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0478-9 · Cited by 84
Self-citationDiana, T., Krause, J., Olivo, P. D., König, J., Kanitz, M., Decallonne, B., & Kahaly, G. J. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12980 · Cited by 84
Self-citationShiber, S., Stiebel‐Kalish, H., Shimon, I., Grossman, A., & Robenshtok, E. (2014) · Thyroid · doi:10.1089/thy.2014.0218 · Cited by 82
Update in TSH Receptor Agonists and Antagonists
Gershengorn, M. C., & Neumann, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3080 · Cited by 81
Treatment Options for Graves Disease: A Cost-Effectiveness Analysis
In, H., Pearce, E. N., Wong, A. K. G., Burgess, J. F., McAneny, D. B., & Rosen, J. E. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.03.025 · Cited by 81
Kahaly, G. J., Bartalena, L., & Hegedüs, L. (2011) · Thyroid® · doi:10.1089/thy.2011.2106.ed3 · Cited by 80
Self-citationElbers, L. P. B., Mourits, M. P., & Wiersinga, W. M. (2010) · Thyroid · doi:10.1089/thy.2010.0181 · Cited by 80
Bartalena, L., Chiovato, L., & Vitti, P. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0505-x · Cited by 80
Self-citationNovel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins
Lytton, S. D., Li, Y., Olivo, P. D., Kohn, L. D., & Kahaly, G. J. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04266.x · Cited by 77
Self-citationGuo, Z., Yu, P., Liu, Z., Si, Y., & Jin, M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12209 · Cited by 75
Andersen, S. L., Olsen, J., Carlé, A., & Laurberg, P. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3588 · Cited by 74
FETAL HYPERTHYROIDISM: EXPERIENCE OF TREATMENT IN FOUR SIBLINGS
Cove, D. H., & Johnston, P. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91148-1 · Cited by 72
Vitti, P., Rago, T., Mancusi, F., Pallini, S., Tonacchera, M., Santini, F., Chiovato, L., Marcocci, C., & Pinchera, A. (1992) · European Journal of Endocrinology · doi:10.1530/acta.0.1260128 · Cited by 72
Treatment and management of thyroid storm: analysis of the nationwide surveys
Isozaki, O., Satoh, T., Wakino, S., Suzuki, A., Iburi, T., Tsuboi, K., Kanamoto, N., Otani, H., Furukawa, Y., Teramukai, S., et al. (2015) · Clinical Endocrinology · doi:10.1111/cen.12949 · Cited by 71
Fassi, D. E., Nielsen, C. H., Hasselbalch, H. C., & Hegedűs, L. D. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02140 · Cited by 70
Self-citationKampmann, E., Diana, T., Kanitz, M., Hoppe, D., & Kahaly, G. J. (2015) · International Journal of Endocrinology · doi:10.1155/2015/678194 · Cited by 69
Self-citationStandardization of a Bioassay for Thyrotropin Receptor Stimulating Autoantibodies
Diana, T., Kanitz, M., Lehmann, M., et al. (2014) · Thyroid · doi:10.1089/thy.2014.0346 · Cited by 68
Performance and Specificity of 6 Immunoassays for TSH Receptor Antibodies: A Multicenter Study
Diana, T., Wüster, C. C., Olivo, P. D., Unterrainer, A., König, J., Kanitz, M., Bossowski, A. T., Decallonne, B., & Kahaly, G. J. (2017) · European Thyroid Journal · doi:10.1159/000478522 · Cited by 67
Self-citationNICHOLAS, W. C., FISCHER, R. G., STEVENSON, R. A., & BASS, J. D. (1995) · Southern Medical Journal · doi:10.1097/00007611-199509000-00018 · Cited by 64
Nygaard, B., Hegedűs, L. D., Gervil, M., Hjalgrim, H., HANSEN, B. M., Søe‐Jensen, P., & Hansen, J. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01230.x · Cited by 64
Self-citationAnalytical Performance and Clinical Utility of a Bioassay for Thyroid-Stimulating Immunoglobulins
Leschik, J. J., Diana, T., Olivo, P. D., et al. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcpzut7cnueu7op · Cited by 64
Antithyroid drug-induced fetal goitrous hypothyroidism
Bliddal, S., Rasmussen, Å. K., Sundberg, K., Brocks, V., & Feldt‐Rasmussen, U. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.34 · Cited by 63
Mechanisms of Action of TSHR Autoantibodies
Furmaniak, J., Sanders, J. F., Miguel, R. N., & Smith, B. R. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1559648 · Cited by 63
Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy
Ponto, K. A., Diana, T., Binder, H., Matheis, N., Pitz, S., Pfeiffer, N., & Kahaly, G. J. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0254-2 · Cited by 61
Self-citationYang, J. J., Zhu, Y., Zhong, J., Zhang, J., Weng, W.-W., Liu, Z.-F., Xu, Q., & Dong, M. (2016) · Thyroid · doi:10.1089/thy.2015.0439 · Cited by 60
Léger, J., & Carel, J. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0938 · Cited by 59
Bartalena, L., Macchia, P. E., Marcocci, C., Salvi, M., & Vermiglio, F. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0257-z · Cited by 58
Self-citationThe Cost Effectiveness of Treatment Modalities for Thyrotoxicosis in a U.K. Center
Patel, N., Abraham, P., Buscombe, J. R., & Vanderpump, M. P. J. (2006) · Thyroid · doi:10.1089/thy.2006.16.593 · Cited by 56
Kahaly, G. J., & Olivo, P. D. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1614624 · Cited by 56
Self-citationTSH Receptor Antibody Functionality and Nomenclature
Kahaly, G. J., & Diana, T. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00028 · Cited by 54
Self-citationGiuliani, C., Cerrone, D., Harii, N., Thornton, M. O., Kohn, L. D., Dagia, N. M., Bucci, I., Carpentieri, M. S., Nenno, B. D., Blasio, A. D., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2897 · Cited by 52
TSI assay utilization: impact on costs of Graves' hyperthyroidism diagnosis.
McKee, A., & Peyerl, F. W. (2012) · PubMed · Cited by 48
Donovan, P. J., McLeod, D. S. A., Little, R. F., & Gordon, L. G. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0527 · Cited by 48
Bonnema, S., Bennedbaek, F., Gram, J., Veje, A., Marving, J., & Hegedus, L. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490485 · Cited by 47
Weetman, A. P. (2014) · Clinical Endocrinology · doi:10.1111/cen.12427 · Cited by 46
Analytical Performance and Validation of a Bioassay for Thyroid-Blocking Antibodies
Diana, T., Li, Y., Olivo, P. D., Lackner, K. J., Kim, H., Kanitz, M., & Kahaly, G. J. (2016) · Thyroid · doi:10.1089/thy.2015.0447 · Cited by 44
Self-citationBioassays for TSH Receptor Antibodies: Quo Vadis?
Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000375445 · Cited by 41
Self-citationGlucocorticoids do not influence the effect of radioiodine therapy in Graves’ disease
Jensen, B. E. S., Bonnema, S. J., & Hegedűs, L. D. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01924 · Cited by 41
Self-citationImportance of tsh receptor activation in the development of severe endocrine ophthalmopathy
Karlsson, F. A., Dahlberg, P. A., Jansson‐Löfmark, R., et al. (1989) · European Journal of Endocrinology · Cited by 40
Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves’ Disease
Inaba, H., DeGroot, L. J., & Akamizu, T. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00120 · Cited by 39
Fetal/neonatal Thyrotoxicosis in a Newborn From a Hypothyroid Woman With Hashimoto’s Thyroiditis
Kiefer, F. W., Klebermaß-Schrehof, K., Steiner, M., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2999 · Cited by 34
Araki, N., Iida, M., Amino, N., Morita, S., Ide, A., Nishihara, E., Ito, M., Saito, J., Nishikawa, T., Katsuragi, K., et al. (2015) · European Thyroid Journal · doi:10.1159/000371740 · Cited by 33
Radioiodine treatment for pediatric Graves' disease
Ma, C., Kuang, A., Xie, J., & Liu, G. J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006294.pub2 · Cited by 33
Survey of Clinical Practice Patterns in the Management of 992 Hyperthyroid Patients in France
Goichot, B., Bouée, S., Castello-Bridoux, C., & Caron, P. J. (2017) · European Thyroid Journal · doi:10.1159/000453260 · Cited by 29
Kim, T. K., & Lee, E. J. (2015) · ULTRASONOGRAPHY · doi:10.14366/usg.14059 · Cited by 28
Zanocco, K. A., Heller, M., Elaraj, D. M., & Sturgeon, C. (2012) · Surgery · doi:10.1016/j.surg.2012.02.020 · Cited by 26
Outcomes analysis of radioactive iodine and total thyroidectomy for pediatric Graves’ disease
Cohen, R. Z., Felner, E. I., Heiss, K. F., Wyly, J. B., & MUIR, A. B. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0333 · Cited by 26
Functional TSH receptor antibodies in children with autoimmune thyroid diseases
Stożek, K., Bossowski, A. T., Ziora, K. T., Bossowska, A., Mrugacz, M., Noczyńska, A., Walczak, M., Petriczko, E., Pyrżak, B., Kucharská, A., et al. (2018) · Autoimmunity · doi:10.1080/08916934.2018.1431776 · Cited by 24
Self-citationFerløv-Schwensen, C., Brandt, F., Hegedűs, L. D., & Brix, T. H. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0954 · Cited by 23
Self-citationThe Natural History of Subclinical Hyperthyroidism in Graves’ Disease: The Rule of Thirds
Zhyzhneuskaya, S., Addison, C., Tsatlidis, V., Weaver, J. U., & Razvi, S. (2016) · Thyroid · doi:10.1089/thy.2015.0470 · Cited by 22
Laboratory Testing in Hyperthyroidism
Grebe, S. K. G., & Kahaly, G. J. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.05.013 · Cited by 20
Self-citationPlantinga, T. S., Arts, P., Knarren, G., Mulder, A., Wakelkamp, I. M. M. J., Hermus, A., Joosten, L. A. B., Netea, M. G., Bisschop, P. H. L. T., de Herder, W., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.733 · Cited by 17
Fetal Hyperthyroidism Resulted from TSI in a Mother with Hashimoto's Hypothyroidism
Mestman, J. H. (2017) · Clinical Thyroidology · doi:10.1089/ct.2017;29.32-34 · Cited by 6
Cited by
Bartalena, L., Kahaly, G. J., Baldeschi, L., Dayan, C. M., Eckstein, A., Marcocci, C., Marinò, M., Vaidya, B., Wiersinga, W. M., _, _., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0479 · Cited by 1,054
Self-citationConnelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Davies, T. F., Andersen, S., Latif, R., Nagayama, Y., Barbesino, G., Brito, M., Eckstein, A. K., Stagnaro-Green, A., & Kahaly, G. J. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0184-y · Cited by 398
Self-citationEpidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy
Bartalena, L., Piantanida, E., Gallo, D., Lai, A., & Tanda, M. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.615993 · Cited by 369
Self-citationNew insights into the pathogenesis and nonsurgical management of Graves orbitopathy
Taylor, P. N., Zhang, L., Lee, R. W. J., Muller, I., Ezra, D. G., Dayan, C. M., Kahaly, G. J., & Ludgate, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0305-4 · Cited by 315
Self-citation
Metadata
- Authors
- Kahaly, G. J., Bartalena, L., Hegedüs, L., Leenhardt, L., Poppe, K., & Pearce, S. H.
- Venue
- European Thyroid Journal
- Publisher
- Bioscientifica
- Published
- 2018
- Volume
- 7
- Issue
- 4
- Pages
- 167-186
- ISSN
- 2235-0640 (ISSN-L)
- 2235-0802
- OpenAlex
- W2884675353
- Cited by
- 940
- References
- 163
- FWCI
- 58.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.